LX31 Intrinsic Valuation and Fundamental Analysis - Lexicon Pharmaceuticals Inc

L	Lexicon Pharmaceuticals Inc F:LX31	US
	Focusrite PLC F:0FO	UK
C	Cherat Cement Company Ltd KAR:CHCC	PK
	BTCS Inc F:BIC	US
S	Sinda Ltd NYSE:SIND	MX
	Blackline Inc NASDAQ:BL	US
L	Li Auto Inc NASDAQ:LI	CN

Intrinsic Value

LX31 price has not been updated for more than 1 year. This may indicate that the stock has been delisted.

The intrinsic value for Lexicon Pharmaceuticals Inc (LX31) under the Base Case is hidden EUR. Compared with the current market price of 2.894 EUR, the stock appears hidden .

Intrinsic value calculated using Multiples

Locked

Other reference points

Wall St target

€4.776

Do our valuations actually work? See backtest results .

LX31 Intrinsic Value

Unlock

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Current Price €2.89

Intrinsic Value Locked

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

LX31 looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether LX31 usually does or if today's premium is unusual.

See where today’s valuation sits in LX31’s own history and what typically happened over the next 12 months after similar periods.

Show Historical Valuation

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Lexicon Pharmaceuticals Inc.

Explain Valuation